LAUREN BAKER: Open Payments
NPI 1225699325 · SENATOBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 8 payments from 7 companies in 2025. Trend: 2023 $308 · 2024 $604 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $37 |
| OptumHealth Care Solutions, LLC | 1 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VIVIFY HEALTH CARE TEAM PORTAL 001, NEFFY, Ozempic, Kerendia, Saxenda, XIFAXAN, MOUNJARO, CAPLYTA.
Industry payments across MS — which companies pay providers there.
